Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1018 publications
Expanded indication for PCSK9 inhibitors.
Journal: The Medical letter on drugs and therapeutics
Published: December 15, 2025
Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes after Acute Coronary Syndrome.
Journal: Circulation
Published: December 01, 2025
PCSK9 Inhibition Protects Against Myocardial Ischemia-Reperfusion Injury in Type 2 Diabetes Rats Via Suppressing Inflammation and Apoptosis.
Journal: Anatolian journal of cardiology
Published: November 17, 2025
Cardiac Allograft Vasculopathy Inhibition with Alirocumab: The CAVIAR Trial.
Journal: Circulation
Published: November 10, 2025
Cost-effectiveness of non-statin lipid-lowering therapies as an add-on to statins for achieving low-density lipoprotein cholesterol therapeutic targets in very high-risk patients in the Spanish setting.
Journal: Journal of medical economics
Published: October 20, 2025
Cost-effectiveness of non-statin lipid-lowering therapies as an add-on to statins for achieving low-density lipoprotein cholesterol therapeutic targets in very high-risk patients in the Spanish setting.
Journal: Journal of medical economics
Published: October 20, 2025
Challenges in the Choice of Nonstatin Medications for Low-Density Lipoprotein-C Lowering for Cardiovascular Risk Reduction.
Journal: Journal of the American Heart Association
Published: October 09, 2025
Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: September 25, 2025
Cost-utility analysis of PCSK9 inhibitors for hypercholesterolemia: a Chinese healthcare perspective.
Journal: Frontiers in pharmacology
Published: September 19, 2025
Effectiveness of PCSK9 inhibitors versus statins in type 2 diabetes and dyslipidemia: a propensity-matched study.
Journal: Frontiers in endocrinology
Published: September 19, 2025
Relative Efficacy of Alirocumab, Evolocumab, Inclisiran, and Bempedoic Acid on Lipids in Patients with Cardiovascular Disease or Familial Hypercholesterolaemia.
Journal: Journal of clinical medicine
Published: September 18, 2025
Last Updated: 01/07/2026